Russia’s drugs chief hailed a new agreement Thursday with Washington to boost joint anti-drug efforts, but he also urged the United States and NATO to do more to stop Afghan drugs.
The deal — signed by Gil Kerlikowske, director of the U.S. Office of National Drug Control Policy, and Federal Drug Control Service chief Viktor Ivanov — envisions setting up groups of experts to plan joint action in combating drugs and also steps to curb demand for drugs, toughen law enforcement, and coordinate legislation.
Kerlikowske told reporters after the meeting that he promised Ivanov to monitor and assess the U.S. and Afghan governments’ efforts to “interdict drug supplies.”
Ivanov hailed the agreement as a key component of U.S.-Russian efforts to “reset” relations, adding: “The efficiency of international drug-fighting efforts in Afghanistan needs to be strengthened,” Ivanov said.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.